Citation: | Li Shengbing, Chen Wen, Li Xiubin, et al. The application value of Multi-Latex polygranular technique joint detection of urinary microproteins in noninvasive diagnosis after renal transplantation[J]. ORGAN TRANSPLANTATION, 2020, 11(4): 443-448. doi: 10.3969/j.issn.1674-7445.2020.04.003 |
[1] |
DAUBER EM, KOLLMANN D, KOZAKOWSKI N, et al. Quantitative PCR of INDELs to measure donor-derived cell-free DNA-a potential method to detect acute rejection in kidney transplantation: a pilot study[J]. Transpl Int, 2020, 33(3):298-309. DOI: 10.1111/tri.13554.
|
[2] |
ALBERT C, HAASE M, ALBERT A, et al. Urinary biomarkers may complement the Cleveland score for prediction of adverse kidney events after cardiac surgery: a pilot study[J]. Ann Lab Med, 2020, 40(2):131-141. DOI: 10.3343/alm.2020.40.2.131.
|
[3] |
彭景, 唐怡.尿液L-FABP及KIM-1水平用于HBV相关ACLF患者并发AKI的诊断价值[J].肝脏, 2018, 23 (11):959-963. DOI: 10.3969/j.issn.1008-1704.2018.11.007.
PENG J, TANG Y. Research of diagnostic value of urinary L-FABP and KIM-1 levels in HBV-related ACLF patients with AKI[J]. Chin Hepatol, 2018, 23(11):959-963. DOI: 10.3969/j.issn.1008-1704.2018.11.007.
|
[4] |
JUNG HY, LEE CH, CHOI JY, et al. Potential urinary extracellular vesicle protein biomarkers of chronic active antibody-mediated rejection in kidney transplant recipients[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2020, 1138:121958. DOI: 10.1016/j.jchromb. 2019.121958.
|
[5] |
LAMB KE, LODHI S, MEIER-KRIESCHE HU. Long-term renal allograft survival in the United States: a critical reappraisal[J]. Am J Transplant, 2011, 11(3):450-462. DOI: 10.1111/j.1600-6143.2010.03283.x.
|
[6] |
JACQUEMONT L, SOULILLOU JP, DEGAUQUE N. Blood biomarkers of kidney transplant rejection, an endless search?[J]. Expert Rev Mol Diagn, 2017, 17(7):687-697. DOI: 10.1080/14737159.2017.1337512.
|
[7] |
SOLEZ K, COLVIN RB, RACUSEN LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions[J]. Am J Transplant, 2008, 8(4):753-760. DOI: 10.1111/j.1600-6143.2008.02159.x.
|
[8] |
COLVIN RB, COHEN AH, SAIONTZ C, et al. Evaluation of pathologic criteria for acute renal allograft rejection: reproducibility, sensitivity, and clinical correlation[J]. J Am Soc Nephrol, 1997, 8(12):1930-1941. http://europepmc.org/abstract/MED/9402096
|
[9] |
JOELSONS G, DOMENICO T, GONÇALVES LF, et al. Non-invasive messenger RNA transcriptional evaluation in human kidney allograft dysfunction[J]. Braz J Med Biol Res, 2018, 51(7):e6904. DOI: 10.1590/1414-431x20186904.
|
[10] |
RUAN Y, GUO W, LIANG S, et al. Diagnostic performance of cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in kidney transplantation: a PRISMA-compliant article[J]. Medicine (Baltimore), 2019, 98(16):e15228. DOI: 10.1097/MD.0000000000015228.
|
[11] |
PANAGOPOULOU MS, WARK AW, BIRCH DJS, et al. Phenotypic analysis of extracellular vesicles: a review on the applications of fluorescence[J]. J Extracell Vesicles, 2020, 9(1):1710020. DOI: 10.1080/20013078.2019.1710020.
|
[12] |
WOUTERS S, DE VOS J, DORES-SOUSA JL, et al. Prototyping of thermoplastic microfluidic chips and their application in high-performance liquid chromatography separations of small molecules[J]. J Chromatogr A, 2017, 1523:224-233. DOI: 10.1016/j.chroma.2017.05.063.
|
[13] |
VAN DE VRIE M, DEEGENS JK, EIKMANS M, et al. Urinary microRNA as biomarker in renal transplantation[J]. Am J Transplant, 2017, 17(5):1160-1166. DOI: 10.1111/ajt.14082.
|
[14] |
DING R, LI B, MUTHUKUMAR T, et al. CD103 mRNA levels in urinary cells predict acute rejection of renal allografts[J]. Transplantation, 2003, 75(8):1307-1312. doi: 10.1097/01.TP.0000064210.92444.B5
|
[15] |
RENESTO PG, PONCIANO VC, CENEDEZE MA, et al. High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection[J]. Am J Transplant, 2007, 7(6):1661-1665. http://cn.bing.com/academic/profile?id=863dfe5b6879cd0e4bc4e4319a97e4d9&encoded=0&v=paper_preview&mkt=zh-cn
|
[16] |
MATZ M, BEYER J, WUNSCH D, et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function[J]. Kidney Int, 2006, 69(9):1683-1690. doi: 10.1038/sj.ki.5000343
|
[17] |
VAN DEN AKKER EK, DOR FJ, IJZERMANS JN, et al. MicroRNAs in kidney transplantation: living up to their expectations?[J]. J Transplant, 2015:354826. DOI: 10.1155/2015/354826.
|
[18] |
AL-NEDAWI K, HAAS-NEILL S, GANGJI A, et al. Circulating microvesicle protein is associated with renal transplant outcome[J]. Transpl Immunol, 2019, 55:101210. DOI: 10.1016/j.trim.2019.06.002.
|
[19] |
AKBARI A, WHITE CA, SHAHBAZI N, et al. Spot urine protein measurements: are these accurate in kidney transplant recipients?[J]. Transplantation, 2012, 94(4):389-395. doi: 10.1097/TP.0b013e31825b413e
|
[20] |
罗百文, 邓新强, 范向平, 等.四项尿微量蛋白定量检测在糖尿病肾病早期诊断中的应用价值[J].中国现代医药杂志, 2019, 21(11):87-89.DOI: 10.3969/j.issn.1672-9463.2019.11.025.
LUO BW, DENG XQ, FAN XP, et al. Application value of four quantitative urine microprotein detections in early diagnosis of diabetic nephropathy[J]. Mod Med J Chin, 2019, 21(11):87-89. DOI: 10.3969/j.issn.1672-9463.2019.11.025.
|
[21] |
林志强, 刘继来, 林青, 等.尿微量白蛋白/尿肌酐、尿转铁蛋白/尿肌酐、尿α1M/尿肌酐、尿免疫球蛋白/尿肌酐参考区间建立[J].临床合理用药杂志, 2017, 10 (31):167-169. DOI: 10.15887/j.cnki.13-1389/r.2017.31.097.
LIN ZQ, LIU JL, LIN Q, et al. Establishment of urine microalbumin / urinary creatinine, urine transferrin / urinary creatinine, urine α1M / urinary creatinine, urine immunoglobulin / urinary creatinine reference intervals[J]. Chin J Clin Ration Drug Use, 2017, 10(31):167-169. DOI: 10.15887/j.cnki.13-1389/r.2017.31.097.
|
[22] |
刘芳, 薛林霞.血清CysC、尿β2-MG、L-FABP联合检测对心脏手术后急性肾损伤的早期诊断价值[J].中国医师杂志, 2019, 21 (12): 1817-1820, 1824. DOI: 10.3760/cma.j.issn.1008-1372.2019.12.015.
LIU F, XUE LX. Early diagnosis value of joint detection of serum CysC, urine β2-MG, and L-FABP for acute kidney injury after cardiac surgery[J]. J Chin Physician, 2019, 21 (12): 1817-1820, 1824. DOI: 10.3760/cma.j.issn.1008-1372.2019.12.015.
|
[23] |
ABBASI F, MOOSAIE F, KHALOO P, et al. Neutrophil gelatinase-associated lipocalin and retinol-binding protein-4 as biomarkers for diabetic kidney disease[J]. Kidney Blood Press Res, 2020, 45(2):222-232. DOI: 10.1159/000505155.
|
[24] |
PALLET N, LEGENDRE C. Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach[J]. Pharmacogenomics, 2010, 11(10):1491-1501. DOI: 10.2217/pgs.10.137.
|